Inventor
ABECASIS GONCALO
US11 patents
⚠️ This page may combine multiple inventors who share the name “ABECASIS GONCALO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
10 patentsUS11865134B2Jan 9, 2024
Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7) inhibitors
REGENERON PHARMA0 citations60
US12258627B2Mar 25, 2025
Kelch domain containing 7B (KLHDC7B) variants and uses thereof
REGENERON PHARMA0 citations59
US11820982B2Nov 21, 2023
Treatment of ophthalmic conditions with son of Sevenless 2 (SOS2) inhibitors
REGENERON PHARMA1 citations59
US11674177B2Jun 13, 2023
Kelch domain containing 7B (KLHDC7B) variants and uses thereof
REGENERON PHARMA1 citations59
US11512309B2Nov 29, 2022
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
REGENERON PHARMA0 citations59
US11767526B2Sep 26, 2023
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
REGENERON PHARMA0 citations57
US12264366B2Apr 1, 2025
Genome-based methods for reducing cardiovascular risk
REGENERON PHARMA0 citations56
US11845989B2Dec 19, 2023
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
REGENERON PHARMA0 citations56
US12186378B2Jan 7, 2025
Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonists
REGENERON PHARMA0 citations47
US12070460B2Aug 27, 2024
Methods of treating skin cancer with Carboxypeptidase Vitellogenic Like (CPVL) inhibitors
REGENERON PHARMA0 citations45